Search Finnegan

Conference

2026 China Pharmaceutical Innovation Conference 2026 China Pharmaceutical Innovation Conference

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe 19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

Articles

Skinny Labels, Larger Risks: Supreme Court Considers Induced Infringement Standards in Hikma v. Amarin Skinny Labels, Larger Risks: Supreme Court Considers Induced Infringement Standards in Hikma v. Amarin

Federal Circuit IP Blog

Spotlight on Upcoming Oral Arguments – July 2025 Spotlight on Upcoming Oral Arguments – July 2025

Articles

FDA Draft Guidance on Evaluation of Therapeutic Equivalence FDA Draft Guidance on Evaluation of Therapeutic Equivalence

Webinar On Demand

Frameworks for US Pharma Patent Disputes Frameworks for US Pharma Patent Disputes

Federal Circuit IP Blog

Federal Circuit Sidesteps Determination of Generics’ Skinny Label as Protection Against Induced Infringement Federal Circuit Sidesteps Determination of Generics’ Skinny Label as Protection Against Induced Infringement

Articles

China’s “Hatch-Waxman” System: A Comparative Overview China’s “Hatch-Waxman” System: A Comparative Overview

Articles

Comparative Overview of Drug Patent Linkage Systems in China and the United States Comparative Overview of Drug Patent Linkage Systems in China and the United States